Subcommittee on Neurological Disease committee  It's very effective.

Subcommittee on Neurological Disease committee  Probably.

Subcommittee on Neurological Disease committee  Yes, that's right.

Subcommittee on Neurological Disease committee  Not for awareness, obviously, but for the actual research itself...? How much? Any increase is great; I'm not going to say anything bad about that. We are asking for an across-the-board increase of 1%, and that would benefit all research itself. How much would it be just for the

Subcommittee on Neurological Disease committee  Yes, I think so. From my lab, I know the recent genes we've identified in ALS affect toxicity in our models for Huntington's disease and also our model for Alzheimer's disease. There's a definite crossover. I don't know about Parkinson's because we don't have that in our lab. I

Subcommittee on Neurological Disease committee  The most important aspect is that we need time. However, it is not possible to ask the government to give us time to carry out research work. In the absence of being provided with time, we are asking for financial resources. It is as simple as that. In Montreal, for example, the

Subcommittee on Neurological Disease committee  Yes, for the time being. That is the first stage. Afterwards, what do we do? At present, we have no idea of the way these genes work. This takes time. We need laboratories, obviously, post-doctoral students, technicians, etc. A good project can take maybe two or three years, and

Subcommittee on Neurological Disease committee  I previously worked in the United States on Huntington's, for which a system exists. Let us say that we are successful in finding new drugs that are effective in the model system, be it with a fly, a worm or a mouse. We then move on to clinical trials. There is a system in place

Subcommittee on Neurological Disease committee  Welcome everyone. My name is Alex Parker. I am a researcher at the University of Montreal. I did my doctorate at the University of British Columbia, and then I did my post-doctorate in Paris, France. Allow me to continue in English. For most of my career I've been studying Hunt